Table 2.
Correlation analysis of clinical parameters with levels of fetuin‐A in the whole cohort (a), in ICM patients (b) and dilated cardiomyopathy patients (c)
| Fetuin‐A vs. | r | P |
|---|---|---|
| (a) | ||
| Ejection fraction (%) | −.04 | .70 |
| LVEDd (mm) | .12 | .22 |
| Cholesterol (mg/dL) | .37 | .008* |
| LDL (mg/dL) | .24 | .11 |
| HDL (mg/dL) | .05 | .76 |
| LDL/HDL ratio | .25 | .09* |
| Triglycerides (mg/dL) | .39 | .005* |
| c‐reactive protein (mg/L) | −.01 | .91 |
| BNP (pg/mL) | −.16 | .13 |
| BMI | .34 | <.001* |
| Age | −.36 | <.001* |
| Heart rate (bpm) | .21 | .03 |
| Creatinine (μmol/L) | .003 | .98 |
| Urea (mmol/L) | −.11 | .33 |
| Thrombocytes (×109/L) | .13 | .18 |
| Leucocytes (×109/L) | .14 | .14 |
| Symptoms since (months) | .15 | .19 |
| (b) | ||
| Ejection fraction (%) | .011 | .44 |
| LVEDd (mm) | .15 | .29 |
| Cholesterol (mg/dL) | .37 | .17 |
| LDL (mg/dL) | .15 | .59 |
| HDL (mg/dL) | .02 | .94 |
| LDL/HDL ratio | .20 | .48 |
| Triglycerides (mg/dL) | .45 | .09 |
| c‐reactive protein (mg/L) | .14 | .56 |
| BNP (pg/mL) | −.02 | .88 |
| BMI | .36 | .01* |
| Age | −.19 | .19 |
| Heart rate (bpm) | .22 | .13 |
| Creatinine (μmol/L) | .15 | .38 |
| Urea (mmol/L) | −.09 | .63 |
| Thrombocytes (×109/L) | .14 | .35 |
| Leucocytes (×109/L) | .29 | .05* |
| Symptoms since (months) | .01 | .96 |
| (c) | ||
| Ejection fraction (%) | .02 | .88 |
| LVEDd (mm) | .15 | .25 |
| Cholesterol (mg/dL) | .29 | .09 |
| LDL (mg/dL) | .16 | .38 |
| HDL (mg/dL) | −.08 | .67 |
| LDL/HDL ratio | .24 | .17 |
| Triglycerides (mg/dL) | .47 | .005 |
| c‐reactive protein (mg/L) | .002 | .99 |
| BNP (pg/mL) | .32 | .02* |
| BMI | .38 | .004* |
| Age | −.16 | .24 |
| Heart rate (bpm) | .06 | .65 |
| Creatinine (μmol/L) | .11 | .43 |
| Urea (mmol/L) | −.07 | .62 |
| Thrombocytes (×109/L) | .07 | .60 |
| Leucocytes (×109/L) | .05 | .73 |
| Symptoms since (months) | .26 | .09 |
indicates statistical significance.